1.
Promoting rational antibiotic use in Turkey and among Turkish migrants in Europe – implications of a qualitative study in four countries
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab